Company intelligence / Profile preview

ALS Automated Lab Solutions

Jena, Thuringia, Germany

Ownership: Private
Employees: ~30
Development stage: Other

Overview

ALS Automated Lab Solutions is a laboratory technology company that develops and sells automated cell analysis, selection, isolation, and imaging systems (not therapeutics) used in molecular diagnostics, cancer and stem cell research, cell line development, antibody discovery, and bioprocessing, with its multi‑patented CellCelector platform widely used for rare single cell and colony picking.[1][3][4][7][10]

Industry: Medical Imaging

Partnerships

BioSkryb Genomics – U.S. distribution and technology collaboration combining ALS CellCelector with BioSkryb ResolveDNA single‑cell genomics workflow.[7]

Beyond the preview

Go deeper on ALS Automated Lab Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALS Automated Lab Solutions.

Explore the full profile